港股异动 | 百奥赛图-B(02315)盈喜后涨近13% 预计全年营收增长约40% 纯利增长约400%

Core Viewpoint - The company Baidu Biotechnology (02315) has announced a positive earnings forecast for the fiscal year 2025, leading to a significant increase in its stock price by nearly 13% following the announcement [1] Financial Performance - The company expects to achieve revenue of approximately 1.369 billion to 1.389 billion yuan, representing an increase of 389 million to 408 million yuan compared to the previous year, with a year-on-year growth rate of 39.61% to 41.65% [1] - The anticipated net profit attributable to shareholders is projected to be around 162 million to 182 million yuan, which is an increase of 129 million to 149 million yuan from the previous year, indicating a substantial year-on-year growth of 384.26% to 443.88% [1] Market Dynamics - The company's revenue growth is attributed to the continuous expansion in overseas markets, coupled with a recovery in the domestic biopharmaceutical industry [1] - The high barriers to entry in technology have helped maintain high gross margins, while lean management initiatives have further enhanced operational efficiency, leading to a rapid increase in profitability [1]